跳至主要内容
临床试验/CTRI/2023/07/055135
CTRI/2023/07/055135尚未招募3 期

An Open Label, Prospective, Non-Randomised, Non-Comparative, Single Arm Clinical Study the Effectiveness, Safety and Tolerability of â??FiCollaâ?? from Athos Collagen Private Limited as a Nutritional Supplement for Hair and Nail Health of Adults. - NI

Athos Collagen Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Clinically healthy adult subjects between the ages of 21 and 55 years (both ages and all genders inclusive) looking to improve their Hair and Nail Health.
  • 2. Subjects who have scored greater than or equal 15 in Hair and Nail Health Screening Questionnaire.
  • 3. Subjects who are willing to abstain from the use of herbal, allopathic or other nutritional supplements (interventional) that are indicated at improving hair and nail health.
  • 4. Subjects who are willing to give informed consent for participation, able to comprehend and understand the responsibilities during screening and treatment period.
  • 5. Subjects who are willing not to participate in any other clinical trial during participation in the current trial.

排除标准

  • 1. Subjects with known hypersensitivity to the ingredients of the investigational product
  • 2. Subjects who are on collagens supplements in any form.
  • 3. Subjects who are vegetarians/ vegans who object to consumption of animal origin investigational product.
  • 4. Subjects who had an active dermatological procedure done up to 3 months prior to screening
  • 5. Subjects who have skin condition/ scarring that prevent proper examination or evaluation of study criteria.
  • 6. Subjects who have an active infection, disease or disorder that will prevent them from fully satisfying the responsibilities of the study
  • 7. Subjects with history of seizures, uncontrolled diabetes, hypertension or major cardiac illness like congestive heart failure etc.
  • 8. Subjects on remission from cancer of any type less than 5 years at the time of screening.
  • 9. Subjects who are planning a pregnancy and/or currently breastfeeding.
  • 10. Subjects who have participated in a clinical study less than1 month before screening.
  • 11. Any significant medical condition (e.g., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.) any medical condition that is unstable/poorly controlled or other factor (e.g., planed relocation) that the investigator felt would interfere with study evaluations and study participation.
  • 12. Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocols.
  • 13. Subjects, who in the opinion of the Investigator are not eligible for enrolment in the study.

研究者

发起方
Athos Collagen Private Limited

相似试验